Efficacy and tolerability of anti-tuberculotic chemotherapy in patients with newly diagnosed cavitary infiltrative pulmonary tuberculosis and a high risk of drug resistance in prisons
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.